Sequencing Unit
The sequencing unit at the Biomedical Research Center has successfully established and deployed three high-throughput sequencing platforms: Illumina-MiSeq, MGI-G50, and ONT-GridION. These sequencing platforms provide massively parallel sequencing experiments on various applications starting from targeted sequencing and metagenomics to whole-genome sequencing. The sequencing unit's mission is to conduct state-of-the-art research in genomics, with a focus on the genomics of local habitats and infectious pathogens. The team specializes in the design and development of protocols that offer rapid and accurate identification and characterization of any pathogen of interest. In complementation with other facilities in the center, we were successfully able to isolate, sequence, and characterize viruses from different origins to serve both research and diagnostic purposes. As we are keen to improve infectious disease research in Qatar, the sequencing unit has extended its services to benefit other researchers at Qatar University, Hamad Medical Corporation, and the Ministry of Municipality and Environment. During the COVID-19 pandemic, the sequencing team has led the national efforts to sequence SARS-CoV-2 and has so far sequenced more than 8000 samples. The team has offered outstanding efforts to strengthen the national efforts to control the introduction and spread of SARS-CoV-2 variants by sharing the sequencing data with local authorities and public databases. The team is actively involved in the development of new techniques for whole bacterial genome sequencing, virus genotyping, and metagenomics. in addition to many other massively parallel genetic assays. We also support other researchers through offering consultations on experiment design including sample preparation, library construction, quality check, and analysis of generated sequencing data.
Useful Information
- Location: D138
- PI: BRC
- Contact
-
-